Ascendis Pharma Growth Disorders A/S
3 clinical trials · Sponsor
◉ Watch Ascendis Pharma Growth Disorders A/S
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia (NCT06433557) | Ascendis Pharma Growth Disorders A/S | 2024-07-26 |
| A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia (NCT05929807) | Ascendis Pharma Growth Disorders A/S | 2023-06-21 |
| A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia (NCT05598320) | Ascendis Pharma Growth Disorders A/S | 2023-03-03 |
Track Ascendis Pharma Growth Disorders A/S automatically
Every clearance here is in the API, with alerts when new ones post.